U.S. market Closed. Opens in 20 hours 12 minutes

FUSN | Fusion Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue2.07M1.46M1.44MN/AN/AN/AN/A
Cost of Revenue1.34M58.90M56.36M482.00K290.00KN/AN/A
Gross Profit723.00K-57.43M-54.92M-482.00K-290.00KN/AN/A
Operating Expenses99.95M89.50M83.45M37.94M18.04M9.76M6.99M
Selling, General & Admin31.20M30.60M27.10M20.74M7.59M3.22M1.62M
Research & Development68.76M58.90M56.36M17.19M10.63M6.88M5.37M
Other Operating Expenses762.00K-1.77M469.00K-31.71M-176.00K-1.71MN/A
Operating Income-99.23M-88.03M-82.02M-37.94M-18.22M-10.10M-6.99M
Other Expenses / Income5.12M-1.42M850.00K-37.79M2.28M-1.71M722.00K
Before Tax Income-94.11M-89.45M-81.17M-75.72M-15.94M-11.47M-6.26M
Income Tax Expenses787.00K-1.84M-118.00K2.61M251.00K181.00KN/A
Net Income-94.90M-87.61M-81.05M-78.33M-16.19M-11.65M-6.26M
Interest Expenses5.17M1.80MN/A327.00KN/AN/AN/A
Basic Shares Outstanding65.61M43.75M42.60M22.03M155.71M18.70M18.70M
Diluted Shares Outstanding65.61M43.75M42.60M22.03M155.71M18.70M18.70M
EBITDA-97.89M-87.65M-81.38M-31.05M-17.75M-9.65M-6.24M
EBITDA Margin-4,733.41%-5,999.18%-5,651.46%0.00%0.00%0.00%0.00%
EBIT-88.94M-87.65M-81.17M-75.39M-15.94M-11.47M-6.26M
EBIT Margin-4,300.97%-5,999.18%-5,636.46%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙